In Brief: Shasun Buys Nuprin, DSM And GSK Earnings, Ad Claims Referred To FTC
This article was originally published in The Tan Sheet
Executive Summary
Shasun acquires ibuprofen products; DSM predicts nutrition sales will increase; GSK sales fall on supply chain trouble; Nature’s Medicine Associates’ ad referred to FTC; Heinrich co-sponsors designer steroid bill; and AHPA eases botanical identification burden.